A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
05/2011
05/19/2011	US20110117027 Injectable void filler for soft tissue augmentation
05/19/2011	US20110117026 Methods and compositions for the delivery of bioactive compounds
05/19/2011	US20110117024 Nanocarrier and nanogel compositions
05/19/2011	US20110117018 Compositions and methods for treating bone
05/19/2011	US20110117009 Drug conjugates with polyglycerols
05/19/2011	US20110114524 Storage-stable, functionally intact fibrinogen
05/19/2011	DE202010016235U1 Formulierungen Formulations
05/19/2011	DE102010048788A1 Transdermal system, useful e.g. as monotherapy for indicating e.g. multiple sclerosis, comprises immunomodulator as active agent and active agent-impermeable removable protective coating, adhesive layer and active agent permeable membrane
05/19/2011	CA2781008A1 Ophthalmic preparations based on bdnf (brain-derived neurotrophic factor) and their use
05/19/2011	CA2780948A1 A process for converting a solid (meth)acrylate copolymer into a dispersed form by means of a dispersing agent
05/19/2011	CA2780941A1 Immediate release tablet formulations
05/19/2011	CA2780939A1 Bilayer tablet formulations
05/19/2011	CA2780938A1 Reduced mass metformin formulations
05/19/2011	CA2780898A1 Advanced functional biocompatible foam used as a hemostatic agent for compressible and non-compressible acute wounds
05/19/2011	CA2780860A1 Pharmaceutical composition for external use
05/19/2011	CA2780787A1 Method for preventing the crystallisation of pharmaceuticals in a polymer film
05/19/2011	CA2780493A1 Dynamic thermoresponsive nanoparticles for stabilization of enzymes at high temperatures
05/19/2011	CA2780486A1 Stabilized formulations of fatty acids
05/19/2011	CA2780292A1 Nanosus pens ion of a poorly soluble drug made by microfluidization process
05/19/2011	CA2780256A1 Use of bethanechol for treatment of xerostomia
05/19/2011	CA2780234A1 Polysaccharide gel formulation having multi-stage bioactive agent delivery
05/19/2011	CA2779950A1 Method of inspection of sealed capsules with a process of determination of the quality of the seal and related equipment for in-line inspection
05/18/2011	EP2322615A1 Use of unmethylated CpG oligonucleotides for the treatment of allergy
05/18/2011	EP2322470A2 Method for manufacturing uniform size polymeric nanoparticles containing poorly soluble drugs
05/18/2011	EP2322244A1 Pharmaceutical composition suitable for the treatment of malaria within one day
05/18/2011	EP2322243A1 Pharmaceutical products and compositions comprising formoterol, ciclesonide and tiotropium
05/18/2011	EP2322237A1 Bicarbonate-Based solutions for dialysis therapies
05/18/2011	EP2322236A1 Bicarbonate-based solutions for dialysis therapies
05/18/2011	EP2322234A1 In situ hardening paste, its manufacturing and use
05/18/2011	EP2322233A1 Nanoparticle formulations for treating vascular dissease.
05/18/2011	EP2322227A1 Ph-sensitive dendritic polymeric micelles
05/18/2011	EP2322226A2 Solutions and methods for inhibition of pain, inflammation and cartilage degradation
05/18/2011	EP2322212A1 Compositon of antigen and glycolipid adjuvant for sublingual administration
05/18/2011	EP2322198A2 Pharmaceutical compositions including low dosages of desmopressin
05/18/2011	EP2322197A2 Pharmaceutical compositions including low dosages of desmopressin
05/18/2011	EP2322196A2 Pharmaceutical compositions including low dosages of desmopressin
05/18/2011	EP2322195A2 Pharmaceutical compositions including low dosages of desmopressin
05/18/2011	EP2322194A2 Pharmaceutical compositions including low dosages of desmopressin
05/18/2011	EP2322188A1 Treatment of Inflammatory and Hyperproliferative Skin disease
05/18/2011	EP2322181A2 A pentoxifilin-based dermatological pharmaceutical composition, for topical application, in cream, gel, ointment, solution, emulsion, liposome and microcapsule form
05/18/2011	EP2322179A1 Pharmaceutical Compositions Comprising Dextromethorphan and Quinidine for the Treatment of Neurological Disorders
05/18/2011	EP2322177A1 Use of a preparation based on nifedipine for treating vaginismus
05/18/2011	EP2322175A1 Pharmaceutical composition for treating hypertension and metabolic syndrome and use thereof
05/18/2011	EP2322170A1 Minimizing adverse experience associated with oxybutynin therapy
05/18/2011	EP2322165A1 Apo2 ligand/TRAIL formulations
05/18/2011	EP2322161A1 Composition for preventing and treating odontostomatological pathologies of animals
05/18/2011	EP2322160A1 Methods of inducing terminal differentiation
05/18/2011	EP2322158A2 Resveratrol and/or grape leaf extract for energy metabolism activation
05/18/2011	EP2322151A2 Sustained release formulation comprising a GPR119 agonist and a DPP-IV inhibitor
05/18/2011	EP2322150A2 Method of identifying GLP-1 secretagogues
05/18/2011	EP2322148A2 Aroma therapy patch
05/18/2011	EP2322147A1 Use of microparticles containing genetically modified cells in the treatment of neurodegenerative diseases
05/18/2011	EP2322146A2 Microcapsule formulations comprising two pharmaceutically active ingredients
05/18/2011	EP2322145A1 Material mixture based on a mixture of ether oils and use of same
05/18/2011	EP2322144A1 Apparatus for preparing a sugar-coated agent
05/18/2011	EP2322143A1 Method for utilizing neutral lipids to modify in vivo release from multivesicular liposomes
05/18/2011	EP2322142A1 Bio-compatible, magnetic nano-particles for handling glioblastoma
05/18/2011	EP2322137A1 Stable hydroalcoholic compositions
05/18/2011	EP2321640A1 Formulation for oral administration of proteins
05/18/2011	EP2321264A2 Deacetylase inhibitors and uses thereof
05/18/2011	EP2321039A1 Wet granulation system comprising at least one ultrasonic nozzle
05/18/2011	EP2321023A1 Process for improving crystallinity of fluticasone particles
05/18/2011	EP2321022A1 Process for improving crystallinity
05/18/2011	EP2320949A2 Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
05/18/2011	EP2320920A2 Topical anti-inflammatory combination
05/18/2011	EP2320915A1 Gentle, non-irritating, non-alcohoholic skin disinfectant
05/18/2011	EP2320911A1 Vasoconstriction compositions and methods of use
05/18/2011	EP2320893A1 Combination of a triptan and an nsaid
05/18/2011	EP2320879A2 Pharmaceutical composition comprising jasmonates
05/18/2011	EP2320877A1 Treatment of acute myocardial infarction (ami) using encapsulated cells encoding and secreting glp-1 peptides or analogs thereof
05/18/2011	EP2320876A2 Hydroxypropyl cellulose capsule shell
05/18/2011	EP2320875A1 Secure tracking of tablets
05/18/2011	EP2320874A1 Solid pharmaceutical composition comprising exemestane
05/18/2011	EP2320873A1 Telmisartan tablets
05/18/2011	EP2320872A2 Process for preparing microparticles
05/18/2011	EP2320871A1 Intravaginal devices with a rigid support, methods of making, and uses thereof
05/18/2011	EP2320870A1 Topical intranasal composition usable in the case of nasal obstruction
05/18/2011	EP2320754A2 Microemulsion
05/18/2011	EP2320740A1 Pharmaceutical compositions and methods for producing low impurity concentrations of the same
05/18/2011	EP2224820B1 Comestible products
05/18/2011	EP2034967B1 Oral pharmaceutical composition of a poorly water-soluble active substance
05/18/2011	EP1945533B1 Aerosol valve
05/18/2011	EP1786397B1 Phenytoin formulations, and uses thereof in wound healing
05/18/2011	EP1765350B1 Manufacturing method of solid dispersion containing itraconazole
05/18/2011	EP1686962B1 Nanoparticulate compositions having a peptide as a surface stabilizer
05/18/2011	EP1589945B1 Topical pharmaceutical and/or cosmetic dispense systems
05/18/2011	EP1539664B1 Crystallization of polyol compositions, crystalline polyol composition product and use thereof
05/18/2011	EP1499359B1 Temperature responsive delivery systems
05/18/2011	EP1469900B1 Humidity-tight cartridge for a powder inhaler
05/18/2011	EP1379499B1 New diaminedithiol derivatives and radiorhenium or radiotechnetium complex thereof; a liver cancer-treating composition comprising the radiorhenium complex and lipiodol; and a kit for preparation of the liver cancer-treating composition
05/18/2011	CN201832163U Novel prepared slice of traditional Chinese medicine
05/18/2011	CN1976685B Oral antimicrobial pharmaceutical compositions
05/18/2011	CN1929826B Pharmaceutical composition for topical use in form of xerogels or films and methods for production
05/18/2011	CN1913873B Medical product containing tiotropium incorporated in a waterproof container
05/18/2011	CN1905858B Composition and delivery system
05/18/2011	CN1872080B Drop pills of thevetoside and preparation method
05/18/2011	CN1785221B Powder injection containing radix bupleuri and its preparation method
05/18/2011	CN1727340B Temozolomide 8-carboxylic ester, and combination
05/18/2011	CN1700909B Treatment solution and application for preventing posterior capsular opacification by selectively inducing detachment and/or death of lens epithelial cells
05/18/2011	CN1642524B Site specific delivery of co-administered drugs via inhalation

1 ... 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 ... 2991